Moreover, it has been also demonstrated that glioma tumorigenesis and malignancy were facilitated by upregulated FOXD2-AS1 through downregulating miR-185-5p and increasing CCND2 expression [10]. The gene discussed is FOXD2; the disease is central nervous system cancer.